Filing Flows

Filing Flows › Companies › AbCellera Biologics › Earnings quality

AbCellera Biologics earnings quality score

How much of the reported profit is backed by cash, and how many markers of managed earnings the filings show

Score52 / 100 · grade C · rank 854 of 1027

AbCellera Biologics (ABCL) scores 52 of 100 for earnings quality, grade C: rank 854 of 1027 companies and 103 of 126 in health. It loses the most points on accruals of -1.1% of assets, higher than 79% of companies, discretionary accruals of -8.2% of assets (modified Jones), larger than most, Montier C-score 1 of 4 checks failed. It earns full or near-full marks for adjusted earnings 2% below GAAP, profit about as variable as cash flow (smoothness 0.96). Revenue grew 101% in the year: fast growth raises accruals, the Beneish and Dechow scores and the C-score by construction, so a growing company scores lower than a steady one with the same accounting.

What earned and lost points

ComponentWhat the filings showPointsOf
Accrualsaccruals of -1.1% of assets, higher than 79% of companies733
Montier C-scoreMontier C-score 1 of 4 checks failed1925
Discretionary accrualsdiscretionary accruals of -8.2% of assets (modified Jones), larger than most317
Non-GAAP gapadjusted earnings 2% below GAAP1617
Earnings smoothnessprofit about as variable as cash flow (smoothness 0.96)88
ABCL: share of the available points, by componentABCL: share of the available points, by componentAccruals21%Discretionary accruals16%Montier C-score75%Non-GAAP gap93%Earnings smoothness100%

How the score is built

Eight published measures, each scored against the whole universe or on its own scale and weighted: accruals 20, discretionary accruals 10, Beneish M 15, Dechow F 15, Montier C 15, Piotroski F 10, the non-GAAP gap 10, smoothness 5. A measure that cannot be computed (Beneish for a bank, say) drops out and the rest is rescaled, so every company is scored on what applies to it.

Every company ranked → The full quality workbench, live → AbCellera Biologics: cash flow →

Computed from the companies’ own XBRL filings (latest fiscal year) by published formulas; a statistical screen, not an audit or an accusation. A low score means the reported profit shows more of the markers of managed or low-quality earnings than its peers. Not investment advice.